Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|July 16, 2021
Case Report: Very Late, Atypical Extra-Medullary Relapse in a Patient With Acute Promyelocytic Leukemia (APL) Rescued With a Transplant-Free ApproachMatteo Molica, Carla Mazzone, Tiziana Ottone, et al.
Leukemia Research|May 9, 2007
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemiaStefano Molica, Giovanna Cutrona, Gaetano Vitelli, et al.
Expert Review of Hematology|May 19, 2020
A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemiaSaveria Capria, Matteo Molica, Sara Mohamed, et al.
Clinical Advances in Hematology & Oncology : H&O|December 19, 2019
Treatment-free remission in chronic myeloid leukemiaMatteo Molica, Kiran Naqvi, Jorge E Cortes, et al.
Annals of Hematology|June 7, 2019
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practiceEmilia Scalzulli, Matteo Molica, Danilo Alunni Fegatelli, et al.
Oncotarget|February 28, 2018
Prognostic factors associated with a stable MR4.5 achievement in chronic myeloid leukemia patients treated with imatinibMassimo Breccia, Matteo Molica, Gioia Colafigli, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 10, 2016
Life-Threatening Autoimmune Hemolytic Anemia and Idhiopatic Thrombocytopenic Purpura. Successful Selective Splenic Artery EmbolizationMatteo Molica, Fulvio Massaro, Giorgia Annechini, et al.
European Journal of Haematology|June 16, 2010
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Caterina Battaglia, et al.
Leukemia Research|November 4, 2011
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL)Stefano Molica, Giovanna Digiesi, Anna Antenucci, et al.
Critical Reviews in Oncology/Hematology|November 9, 2016
Proposal for a tailored stratification at baseline and monitoring of cardiovascular effects during follow-up in chronic phase chronic myeloid leukemia patients treated with nilotinib frontlineMassimo Breccia, Eleonora Arboscello, Andrea Bellodi, et al.
Pageof 9